Study of Denosumab in Subjects With Giant Cell Tumor of Bone
NCT00680992
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
535
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Giant Cell Tumors
Giant Cell Tumor of Bone
Benign Giant Cell Tumors
Interventions
DRUG:
Denosumab
Sponsor
Amgen